Publications | Lund University Publications

21 – 30 of 39

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+v1001382&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2023
Mark Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma : The Swedish MCL complete Project
Jerkeman, Mats ^LU ; Ekberg, Sara ^LU ; Glimelius, Ingrid ; Albertsson-Lindblad, Alexandra ^LU ; Entrop, Joshua P. ; Ellin, Fredrik ^LU ; Sonnevi, Kristina ; Lewerin, Catharina ; Brandefors, Lena and Smedby, Karin E. (2023) In HemaSphere 7(8). p.928-928
- Contribution to journal › Article
Mark Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Ekberg, Sara ; Smedby, Karin E. ; Albertsson-Lindblad, Alexandra ^LU ; Jerkeman, Mats ^LU ; Weibull, Caroline E. and Glimelius, Ingrid (2023) In Blood Advances 7(5). p.866-874
- Contribution to journal › Article
Mark Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high dose chemotherapy independent of MIPI and complement established high-risk factors
Sandström Gerdtsson, Anna ^LU ; de Matos Rodrigues, Joana ^LU ; Eskelund, Christian Winther ; Husby, Simon ; Gronbaek, Kirsten ; Räty, Riikka ; Kolstad, Arne ; Geisler, Christian H. ; Porwit, Anna ^LU and Jerkeman, Mats ^LU , et al. (2023) In Haematologica 108(4). p.1092-1104
- Contribution to journal › Article
Mark Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe : The SCHOLAR-2 retrospective chart review study
Hess, Georg ; Dreyling, Martin ; Oberic, Lucie ; Gine, Eva ; Zinzani, Pier Luigi ; Linton, Kim ; Vilmar, Adam ; Jerkeman, Mats ^LU ; Chen, Jenny M.H. and Ohler, Anke , et al. (2023) In British Journal of Haematology 202(4). p.749-759
- Contribution to journal › Article
Mark Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
Nikkarinen, Anna ; Lokhande, Lavanya ^LU ; Amini, Rose Marie ; Jerkeman, Mats ^LU ; Porwit, Anna ^LU ; Molin, Daniel ; Enblad, Gunilla ; Kolstad, Arne ; Räty, Riikka and Hutchings, Martin , et al. (2023) In Blood Advances 7(18). p.5304-5313
- Contribution to journal › Article
Mark Secondary malignancies among mantle cell lymphoma patients
Abalo, Kossi D. ; Smedby, Karin E. ; Ekberg, Sara ^LU ; Eloranta, Sandra ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Jerkeman, Mats ^LU and Glimelius, Ingrid (2023) In European Journal of Cancer 195.
- Contribution to journal › Article
2022
Mark Evalutation of two commercial deep learning OAR segmentation models for prostate cancer treatment
Gorgisyan, Jenny ^LU ; Bengtsson, Ida ; Lempart, Michael ^LU ; Lerner, Minna ^LU ; Wieslander, Elinore ^LU ; Alkner, Sara ^LU and Jamtheim Gustafsson, Christian ^LU (2022) ESTRO 2022
- Contribution to conference › Abstract
Mark Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Merrien, Magali ; Wasik, Agata M. ; Ljung, Elin ; Morsy, Mohammad H.A. ; de Matos Rodrigues, Joana ^LU ; Carlsten, Mattias ; Rassidakis, Georgios Z. ; Christensson, Birger ; Kolstad, Arne and Jerkeman, Mats ^LU , et al. (2022) In Virchows Archiv 480(3). p.655-666
- Contribution to journal › Article
Mark Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Wang, Michael L. ; Jurczak, Wojciech ; Jerkeman, Mats ^LU ; Trotman, Judith ; Zinzani, Pier L. ; Belada, David ; Boccomini, Carola ; Flinn, Ian W. ; Giri, Pratyush and Goy, Andre , et al. (2022) In New England Journal of Medicine 386(26). p.2482-2494
- Contribution to journal › Article
Mark Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population-based study of 736 patients
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ^LU ; Enblad, Gunilla ; El-Galaly, Tarec C. ; Sander, Birgitta ; Sonnevi, Kristina ; Andersson, Per Ola ; Jerkeman, Mats ^LU and Smedby, Karin E. (2022) In British Journal of Haematology 198(2). p.267-277
- Contribution to journal › Article

your query:: Remove department: Oncology corporate